Skip to main content
Premium Trial:

Request an Annual Quote

Sema4: Eli Casdin, Emily Leproust, Jason Ryan, Nat Turner

As part of its merger with special purpose acquisition company CM Life Sciences, Sema4 has appointed four new directors to its board: Eli Casdin, chief investment officer of Casdin Capital; Emily Leproust, CEO of Twist Bioscience; Jason Ryan, former chief operating officer and CFO of Magenta Therapeutics and former CFO of Foundation Medicine; and Nat Turner, cofounder of Flatiron Health.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.